Ray Dalio's ALNT Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 35,558 shares of Allient Inc. (ALNT) worth $1.59 M, representing 0.01% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Ray Dalio has initiated a new position in ALNT, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Allient (ALNT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Allient (ALNT) Trades by Ray Dalio
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2025 | +35,558 | New Buy | 35,558 | $44.75 |
Ray Dalio's Allient Investment FAQs
Ray Dalio first purchased Allient Inc. (ALNT) in Q3 2025, acquiring 35,558 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Allient Inc. (ALNT) for 1 quarters since Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's largest addition to Allient Inc. (ALNT) was in Q3 2025, adding 35,558 shares worth $1.59 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 35,558 shares of Allient Inc. (ALNT), valued at approximately $1.59 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Allient Inc. (ALNT) represents approximately 0.01% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's peak holding in Allient Inc. (ALNT) was 35,558 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.